Trials / Completed
CompletedNCT04724967
CeraVe Diabetes Mellitus
Clinical Evaluation of CeraVe Hydrating Cleanser and Moisturizing Cream for the Improvement of Skin Condition in Patients With Diabetes Mellitus (DM) Related Skin Changes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 528 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin Line for the improvement of skin condition in patients with diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CeraVe Hydrating Cleanser | topical cleanser applied twice a day for 28 days |
| DRUG | CeraVe Moisturizing Cream | topical cream applied twice a day for 28 days |
Timeline
- Start date
- 2021-03-12
- Primary completion
- 2021-08-10
- Completion
- 2021-08-10
- First posted
- 2021-01-26
- Last updated
- 2022-09-22
- Results posted
- 2022-09-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04724967. Inclusion in this directory is not an endorsement.